These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28698350)

  • 41. Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial.
    Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
    Complement Ther Med; 2020 Jun; 51():102428. PubMed ID: 32507439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study.
    Bhatt SP; Misra A; Nigam P; Guleria R; Pasha MA
    PLoS One; 2015; 10(11):e0142260. PubMed ID: 26599361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
    Lorvand Amiri H; Agah S; Mousavi SN; Hosseini AF; Shidfar F
    Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preventive effect of curcumin on inflammation, oxidative stress and insulin resistance in high-fat fed obese rats.
    Maithilikarpagaselvi N; Sridhar MG; Swaminathan RP; Sripradha R
    J Complement Integr Med; 2016 Jun; 13(2):137-43. PubMed ID: 26845728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
    Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
    Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
    Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
    [No Abstract]   [Full Text] [Related]  

  • 47. Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease.
    Manco M; Giordano U; Turchetta A; Fruhwirth R; Ancinelli M; Marcellini M; Nobili V
    Acta Diabetol; 2009 Jun; 46(2):97-104. PubMed ID: 18839055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids.
    Spahis S; Alvarez F; Ahmed N; Dubois J; Jalbout R; Paganelli M; Grzywacz K; Delvin E; Peretti N; Levy E
    J Nutr Biochem; 2018 Aug; 58():28-36. PubMed ID: 29864682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
    Qin Y; Zhou Y; Chen SH; Zhao XL; Ran L; Zeng XL; Wu Y; Chen JL; Kang C; Shu FR; Zhang QY; Mi MT
    PLoS One; 2015; 10(7):e0133496. PubMed ID: 26226139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
    Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Chen S; Zhao X; Ran L; Wan J; Wang X; Qin Y; Shu F; Gao Y; Yuan L; Zhang Q; Mi M
    Dig Liver Dis; 2015 Mar; 47(3):226-32. PubMed ID: 25577300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects.
    Sharma M; Kulkarni A; Kumar P; Nori VB; Jagtap N; Gupta R; Reddy DN; Rao PN
    Sci Rep; 2020 Sep; 10(1):15232. PubMed ID: 32943747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Mirhafez SR; Azimi-Nezhad M; Dehabeh M; Hariri M; Naderan RD; Movahedi A; Abdalla M; Sathyapalan T; Sahebkar A
    Adv Exp Med Biol; 2021; 1308():25-35. PubMed ID: 33861434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
    Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
    Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
    Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects.
    Yang Z; Zhang H; Niu Y; Zhang W; Zhu L; Li X; Lu S; Fan J; Li X; Ning G; Qin L; Su Q
    Sci Rep; 2016 Nov; 6():37886. PubMed ID: 27885258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.
    Paredes-Turrubiarte G; González-Chávez A; Pérez-Tamayo R; Salazar-Vázquez BY; Hernández VS; Garibay-Nieto N; Fragoso JM; Escobedo G
    Clin Exp Med; 2016 May; 16(2):193-202. PubMed ID: 25894568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes.
    Zabihi NA; Pirro M; Johnston TP; Sahebkar A
    Curr Pharm Des; 2017; 23(7):969-982. PubMed ID: 27748192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.